Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
UBS
US Department of Justice
Cipla
AstraZeneca
Moodys
Chinese Patent Office
US Army
Teva
Citi

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,767,251

« Back to Dashboard

Summary for Patent: 5,767,251
Title: Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof
Abstract:Biologically active heterodimeric human fertility hormones composed of two different subunits, each subunit being synthesized in the same cell transformed by at least one cell expression vector having heterologous DNA encoding each subunit with each subunit being controlled by a separate promoter. Preferred human fertility hormones include hCG, hLH and hFSH.
Inventor(s): Reddy; Vermuri B. (Westboro, MA), Hsiung; Nancy (Wellesley, MA), Beck; Anton K. (Grisbeladierbeg, CH), Bernstine; Edward George (Boston, MA)
Assignee: Genzyme Corporation (Cambridge, MA)
Application Number:08/008,233
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 5,767,251

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,767,251

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 169334 ➤ Subscribe
Austria 190461 ➤ Subscribe
Austria 79408 ➤ Subscribe
Austria 87317 ➤ Subscribe
Germany 10199028 ➤ Subscribe
Germany 10199035 ➤ Subscribe
Germany 19675006 ➤ Subscribe
Germany 211894 ➤ Subscribe
Germany 3485869 ➤ Subscribe
Germany 3486469 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Cipla
Chinese Patent Office
Argus Health
Federal Trade Commission
US Army
Julphar
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot